QUEBEC CITY, Aug. 10, 2016 /CNW/ - CO2 Solutions Inc. (or the "Corporation") (TSX-V: CST), the leader in the field of enzyme-enabled carbon capture technology, today announced that broad intellectual property (IP) rights in Denmark have been upheld by the Danish Patent Office. In the re-examination decision, the Danish Patent Office maintained the issued claims in the Corporation's registered Utility Model #BR 201400144 entitled SYSTEM FOR CO2 CAPTURE USING PACKED REACTOR AND ABSORPTION MIXTURE WITH MICRO-PARTICLES INCLUDING BIOCATALYSTS. In fact, all 87 claims of the utility model were maintained in unamended form, meaning that the Corporation's creation, as defined in the claims, is considered to be novel and distinct over the prior art.
The decision came pursuant to a challenge filed by Akermin Inc., a U.S. company that had intended to utilize similar CO2 capture technology for a biogas-related project in Denmark, known as ENZUP. CO2 Solutions had notified Akermin's Danish ENZUP partners of their impending infringement of the Corporation's IP, subsequent to which Akermin filed its challenge.
"This decision is the third in Denmark upholding all of our intellectual property claims in the face of vigorous opposition by Akermin and other ENZUP partners," stated Evan Price, President and Chief Executive Officer of CO2 Solutions. "The decision clearly confirms our ownership of the IP related to enzyme-enabled carbon capture, the most economical and cleanest commercial technology available to date for this purpose. While we offered the ENZUP partners a single commercial licence for use of the CO2 Solutions' IP in their project, it appears that, pursuant to this decision, Akermin has indefinitely ceased operations and the ENZUP project itself, in Denmark, has been cancelled. CO2 Solutions welcomes initiatives to implement carbon capture technology, but shall defend the Corporation's IP wherever we observe actual or imminent infringement on our rights, as we have done successfully in Denmark."
About CO2 Solutions Inc.
CO2 Solutions is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for stationary sources of carbon pollution. CO2 Solutions' technology lowers the cost barrier to Carbon Capture, Sequestration and Utilization (CCSU), positioning it as a viable CO2 mitigation tool, as well as enabling industry to derive profitable new products from these emissions. CO2 Solutions has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post-combustion capture of carbon dioxide with low‐energy aqueous solvents. Further information can be found at www.co2solutions.com.
CO2 Solutions Forward-looking Statements
Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solutions' future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solutions undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE CO2 Solutions Inc.
For further information: Investor Relations and Media Contact: CO2 Solutions: Thom Skinner, 418-842-3456, ext. 223, email@example.com, www.co2solutions.com; NATIONAL Equicom: Marc Lakmaaker, 416-848-1397, MLakmaaker@national.ca